XCancer

Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer

Description:

Study to evaluate the diagnostic precision of ICG and 99mTc nanocolloid albumin in sentinel lymph node detection in early ovarian epithelial cancer.

Sponsor:

Unknown Organization

Phase:

N/A

Contacts:

Aureli Torné, Physician (PRINCIPAL_INVESTIGATOR)

Berta Diaz-Feijoo, Physician (PRINCIPAL_INVESTIGATOR)

Laura Burunat, Graduate (CONTACT)

burunat@recerca.clinic.cat

0034 932275400

Government Study Link:

NCT05937620 - Click here to see study on

ClinicalTrials.gov

Albumin Nanocolloid

Isotope(s):
Target(s):
  • No Explicit Target
Ligand Class: Small Molecules
Inclusion
  • * Patients with adnexal mass diagnosed with high suspicion of malignancy that will undergo intraoperative biopsy or patients with already diagnosed epithelial cancer in early stages in a previous surgery and confirmed by pathology with complete staging indicated.
  • Signing of informed consent by the patient or relative in charge.
  • Women with childbearing potential must compromise to use highly effective contraceptive methods (partner vasectomized, sexual abstinence) until the end of the study (last study visit).
  • Absence of retroperitoneal ganglionary affectation and metastatic disease evaluated by preoperative imaging techniques.
Exclusion
  • Epithelial ovarian tumors stage FIGO III or IV.
  • Impossibility to obtain a biopsy from the tumor.
  • History of previous vascular surgery (cava vein, aorta, iliac blood vessels) or radiotherapy in pelvic or para-aortic area.
  • * Patients \<18 years
  • Pregnancy or breastfeeding